U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07237282) titled 'A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial)' on Nov. 14.
Brief Summary: The purpose of this study is to investigate the safety and antibody (germ fighters) response of the experimental (investigational) vaccine against HCV when injected into the arm of healthy adults.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Hepatitis C
Intervention:
BIOLOGICAL: AVIHepC1
Intramuscular injection administered at 0, 4, and 24 weeks.
BIOLOGICAL: Normal Saline
*Only applicable for double-blinded randomized component of the study. Intramuscular injection administered at 0,...